We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PM:NYSEPhilip Morris International Inc Analysis

Data as of 2026-03-09 - not real-time

$171.35

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Philip Morris International (PM) is trading at $171.35, well above its DCF‑derived fair value of $77.89, indicating the stock is currently overvalued. The price sits comfortably above the 20‑day SMA of 182.53 and the 50‑day SMA of 174.61, but below the 200‑day SMA of 167.48, suggesting a mixed medium‑term trend despite the model flagging a bullish direction. Technical momentum is mixed: the MACD is bearish (line –0.62 vs signal 1.94) while the RSI at 38 hints at near‑oversold conditions, and volume is increasing, supporting a potential short‑term bounce. Fundamentally, the company delivers strong profitability with a gross margin of 67% and operating margin of 33%, and revenue is growing 6.8% YoY, driven by robust smoke‑free product sales. The dividend yield of 3.46% and a payout ratio of 77.6% are supported by solid free cash flow of $8.94 bn, though the balance sheet shows high debt levels and a negative book value per share. Recent analyst upgrades and a live investor webcast underscore confidence in the company’s strategic shift toward reduced‑risk products, but regulatory scrutiny remains a headwind. Overall, the stock offers an attractive dividend and cash generation but appears priced for perfection, with upside limited by valuation and regulatory risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish trend direction with increasing volume
  • MACD bearish divergence and near‑oversold RSI
  • Current price above short‑term support but below resistance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong margins and 6.8% revenue growth driven by smoke‑free products
  • Sustainable dividend yield of 3.46% with solid free cash flow
  • Analyst upgrades and positive investor sentiment (Extreme Greed index)

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Transition to reduced‑risk nicotine products providing growth runway
  • Robust cash generation supporting dividend continuity
  • Brand moat and global footprint offsetting regulatory pressures

Key Metrics & Analysis

Financial Health

Revenue Growth6.80%
Profit Margin27.92%
P/E Ratio23.6
ROA15.96%
P/B Ratio-26.7
Op. Cash Flow$12.2B
Free Cash Flow$8.9B

Technical Analysis

TrendBullish
RSI38.0
Support$166.90
Resistance$191.30
MA 20$182.53
MA 50$174.61
MA 200$167.48
MACDBearish
VolumeIncreasing
Fear & Greed Index100

Valuation

Fair Value$77.89
Target Price$194.84
Upside/Downside13.71%
GradeOvervalued
TypeBlend
Dividend Yield3.46%

Risk Assessment

Beta0.11
Volatility25.81%
Sector RiskLow
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.